Head-To-Head Analysis: Solana (NASDAQ:HSDT) & Disaboom (OTCMKTS:MEDH)

Disaboom (OTCMKTS:MEDH) and Solana (NASDAQ:HSDT) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their dividends, profitability, risk, analyst recommendations, valuation, earnings and institutional ownership.

Institutional and Insider Ownership

18.6% of Solana shares are held by institutional investors. 17.2% of Solana shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Volatility and Risk

Disaboom has a beta of 0.85, meaning that its share price is 15% less volatile than the S&P 500. Comparatively, Solana has a beta of 1, meaning that its share price has a similar volatility profile to the S&P 500.

Profitability

This table compares Disaboom and Solana’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Disaboom	-3.05%	N/A	N/A
Solana	-7,215.25%	-699.93%	-415.24%

Analyst Ratings

This is a breakdown of current ratings for Disaboom and Solana, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Disaboom	0	0	0	0	0.00
Solana	1	0	0	0	1.00

Valuation & Earnings

This table compares Disaboom and Solana”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Disaboom	$890,000.00	0.78	-$170,000.00	N/A	N/A
Solana	$520,000.00	11.07	-$11.74 million	($1,976.28)	0.00

Disaboom has higher revenue and earnings than Solana.

About Disaboom

Dazed, Inc. focuses on retail, distribution, hospitality, licensing, and franchising of portfolio of counterculture brands. The company was formerly known as MedX Holdings, Inc. and changed its name to Dazed, Inc. in October 2022. Dazed, Inc. was founded in 2004 and is based in Cheyenne, Wyoming.

About Solana

Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company was incorporated in 2014 and is headquartered in Newtown, Pennsylvania.